The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis

被引:8
|
作者
Lubrini, Genny [1 ]
Rios Lago, Marcos [2 ,3 ]
Perianez, Jose A. [4 ]
Tallon Barranco, Antonio [1 ]
De Dios, Consuelo [5 ]
Fernandez-Fourier, Mireya [1 ]
Diez Tejedor, Exuperio [1 ]
Frank Garcia, Ana [1 ]
机构
[1] Univ Autonoma Madrid, IdiPAZ Hlth Res Inst, La Paz Univ Hosp, Dept Neurol, Madrid, Spain
[2] Hosp Beata Maria Ana, Brain Damage Serv, Madrid, Spain
[3] UNED, Dept Basic Psychol 2, Madrid, Spain
[4] Univ Complutense Madrid, Dept Basic Psychol 2, Madrid, Spain
[5] Univ Autonoma Madrid, IdiPAZ Hlth Res Inst, La Paz Univ Hosp, Dept Psychiat, Madrid, Spain
关键词
Depression; information processing speed; multiple sclerosis; neuropsychological assessment; Reaction Time; visual search; MAJOR DEPRESSION; WORKING-MEMORY; SPEED; PERFORMANCE; IMPAIRMENT; RELIABILITY; INVENTORY; ATTENTION; CAPACITY; SUBTYPES;
D O I
10.1177/1352458516661047
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Slowness of information processing has been suggested as a fundamental factor modulating cognitive impairment in multiple sclerosis (MS). However, the contribution of depressive symptoms (DS) to slowness remains unclear. One of the most accepted hypotheses on the impact of depression on the general population suggests that depression interferes only with tasks requiring high cognitive demands. However, no studies have investigated if the same pattern occurs in MS. Objective: The aim of this study was to determine the profile of the contribution of DS to slowness. Methods: Four Reaction Time (RT) tasks requiring an increasing level of cognitive demands were administered to 35 relapsing remitting MS patients with DS, 33 MS patients without DS, 17 depressed non-MS patients and 27 controls. Results: MS patients without DS obtained longer RTs than controls in all the tasks. On the contrary, depressed non-MS patients were slower than controls only in the most demanding task. Finally, MS patients with DS were slower than MS patients without DS not only in the most demanding task but also in the task requiring a lower level of cognitive demands. Conclusion: The contribution of DS to slowness depends on the level of cognitive demands. However, its impact on MS is more deleterious than on the general population.
引用
收藏
页码:1607 / 1615
页数:9
相关论文
共 50 条
  • [41] Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
    Lesley J. Scott
    Drugs, 2019, 79 : 875 - 886
  • [42] Depression in relapsing-remitting multiple sclerosis
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 591 - 595
  • [43] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [44] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [45] Moyamoya masquerading as relapsing remitting multiple sclerosis
    Sydney Feldman
    Megan Esch
    Shiv Saidha
    Neurological Sciences, 2019, 40 : 635 - 637
  • [46] Moyamoya masquerading as relapsing remitting multiple sclerosis
    Feldman, Sydney
    Esch, Megan
    Saidha, Shiv
    NEUROLOGICAL SCIENCES, 2019, 40 (03) : 635 - 637
  • [47] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [48] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [49] FADD Is Upregulated in Relapsing Remitting Multiple Sclerosis
    Reuss, Reinhard
    Mistarz, Marta
    Mirau, Andreas
    Kraus, Joerg
    Boedeker, Rolf-Hasso
    Oschmann, Patrick
    NEUROIMMUNOMODULATION, 2014, 21 (05) : 221 - 225
  • [50] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481